Global Analysis: Rise in Protein Drug Use in Hematology and Oncology Boosts Market Outlook (2023-2028)

The anticipated growth of the global PEGylated proteins market is significant, with projections indicating a rise from $10.2 billion in 2023 to $15.9 billion by 2028, reflecting a robust compound annual growth rate (CAGR) of 9.4% over the forecast period.

This comprehensive report delves into the current and future potential of PEGylated proteins, offering an in-depth analysis of market drivers, constraints, and opportunities. It explores the competitive landscape, encompassing pipeline activities of market players and forecasts for 2028. Company profiles spotlight key players, detailing their business segments, financials, product portfolios, and recent advancements, excluding PEGylated vaccines.

Segmented into North America, Europe, Asia-Pacific, and Rest of the World, the report provides market data for the years 2020 to 2022 as historical reference, 2022 as the base year, and projections for 2028.

Key Features:

  • 41 data tables and 22 additional tables
  • Analysis of PEGylated proteins market trends with revenue data spanning 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
  • Insights into market size, revenue growth prospects, and market share analysis by product and services, protein type, application, and region
  • Examination of market drivers, opportunities, restraints, and the influence of macroeconomic factors
  • Analysis of recent patents, emerging technologies, and regulatory considerations
  • Overview of sustainability trends and ESG developments, including consumer attitudes, ESG score rankings, and practices of companies
  • Insight into the competitive landscape, encompassing market shares, business segments, financials, product portfolios, recent M&A activities, and venture funding outlook

Company Profiles:

  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck Kgaa
  • Pfizer Inc.
  • Sandoz Group Ag

Key Attributes:

  • Pages: 74
  • Forecast Period: 2023 – 2028
  • Estimated Market Value (USD) in 2023: $10.2 Billion
  • Forecasted Market Value (USD) by 2028: $15.9 Billion
  • Compound Annual Growth Rate: 9.4%

Key Topics Covered:

  1. Executive Summary
  2. Market Overview
  3. Market Dynamics
  4. Emerging Technologies and Developments
  5. Market Segmentation Analysis
  6. Competitive Intelligence
  7. Sustainability in the PEGylated Proteins Market: ESG Perspective

Source Link

Newsletter Updates

Enter your email address below and subscribe to our newsletter